Cingulate (NASDAQ:CING – Get Free Report) is projected to announce its earnings results before the market opens on Monday, ...

Cingulate (NASDAQ:CING – Get Free Report) is expected to release its earnings data before the market opens on Monday, March 24th. Analysts expect Cingulate to post earnings of ($1.48) per share for ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Roth MKM analyst Boobalan Pachaiyappan maintained a Buy rating on Cingulate Inc (CING – Research Report) today and set a price target of ...

In a report released today, Boobalan Pachaiyappan from Roth MKM maintained a Buy rating on Cingulate Inc (CING – Research Report), with a price ...

Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, along with recent purchases and sales information.

The latest analyst rating for Cingulate (NASDAQ:CING) was provided by HC Wainwright ... so you should get 4 ratings per company per firm each year. The last rating for Cingulate was filed ...

KANSAS CITY, Kan., April 03, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing ...

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical ...